Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment

Review of Diabetic Studies

Volumn 6, Issue 4, 2009, Pages 260-270

  Phadnis, Smruti M ^a,b   Ghaskadbi, Surendra M ^b   Hardikar, Anandwardhan A ^a   Bhonde, Ramesh R ^a,c  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b AGHARKAR RESEARCH INSTITUTE   (India)

^c MANIPAL HOSPITAL   (India)

Author keywords

Beta cell; Bone marrow; Diabetes; Differentiation; NGN3; NKX6.1; PAX6; Stem cell

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; BIOLOGICAL MARKER; C PEPTIDE; ENDOGLIN; FIBRONECTIN; HERMES ANTIGEN; NESTIN; PANCREAS EXTRACT; SMOOTH MUSCLE ACTIN; THY 1 ANTIGEN; VIMENTIN;

ADIPOCYTE; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL AGGREGATION; CELL DIFFERENTIATION; CELL MATURATION; CONFOCAL MICROSCOPY; DIABETES MELLITUS; DIABETIC PATIENT; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; OSTEOCYTE; PANCREAS ISLET CELL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SUPPLEMENTATION;

EID: 75749145849     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.260     Document Type: Article

References (48)

1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007. 132:2131-2157.
2. Li L, Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005. 21:605-631.
3. Gregory CA, Ylostalo J, Prockop DJ. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate. Sci STKE 2005. 2005(294):pe37.
4. Morrison SJ, Kimble J. Asymmetric and symmetric stemcell divisions in development and cancer. Nature 2006. 441(7097):1068-1074.
5. Scadden DT. The stem-cell niche as an entity of action. Nature 2006. 441(7097):1075-1079.
6. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006. 66(9):4553-4557.
7. Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood 2007. 109(7):2688-2692.
8. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mensenchymal stem cells. Science. 1999. 284(5411):143-147.
9. Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, Bosco D, Favrot M, Benhamou PY. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005. 23(4):594-603.
10. Muller I, Lymperi S, Dazzi F. Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr Opin Organ Transplant 2008. 13(6):639-644.
11. Zhang Z, Wang X, Wang S. Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease. In Vitro Cell Dev Biol Anim 2008. 44(5-6):169-177.
12. Ferrero I, Mazzini L, Rustichelli D, Gunetti M, Mareschi K, Testa L, Nasuelli N, Oggioni GD, Fagioli F. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant 2008. 17(3):255-266.
13. Zhao ZG, Liang Y, Li K, Li WM, Li QB, Chen ZC, Zou P. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases. Stem Cells Dev 2007. 16(4):637-648.
14. Drewa T, Joachimiak R, Kaznica A, Flisinski M, Brymora A, Manitius J. Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation. Transplant Proc 2008. 40(5):1668-1673.
15. Lopez-Villar O, Garcia JL, Sanchez-Guijo FM, Robledo C, Villaron EM, Hernández-Campo P, Lopez-Holgado N, Diez-Campelo M, Barbado MV, Perez-Simon JA, et al. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome. Leukemia 2009. 23(4):664-672.
16. Garayoa M, Garcia JL, Santamaria C, Garcia-Gomez A, Blanco JF, Pandiella A, Hernandez JM, Sanchez-Guijo FM, del Canizo MC, Gutierrez NC, San Miguel JF. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia 2009. 23(8):1515-1527.
17. Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, Vlahava VM, Delorme B, Eliopoulos GD, Jorgensen C, et al. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 2008. 67(6):741-749.
18. Banerjee M, Kumar A, Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 2005. 328(1):318-325.
19. Kojima H, Fujimiya M, Matsumura K, Nakahara T, Hara M, Chan L. Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci USA 2004. 101(8):2458-2463.
20. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 2004. 84(5):607-617.
21. Chang C, Niu D, Zhou H, Li F, Gong F. Mesenchymal stem cells contribute to insulin-producing cells upon microenvironmental manipulation in vitro. Transplant Proc 2007. 39(10):3363-3368.
22. Chang C, Niu D, Zhou H, Zhang Y, Li F, Gong F. Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment. Cytotherapy 2008. 10(8):796-805.
23. Chang C, Wang X, Niu D, Zhang Z, Zhao H, Gong F. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment. Pancreas 2009. 38(3):275-281.
24. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997. 276(5309):60-66.
25. Bonner-Weir S, Trent DF, Weir GC. Partial pancreatectomy in the rat and subsequent defect in glucoseinduced insulin release. J Clin Invest 1983. 71(6):1544-1553.
26. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993. 42(12):1715-1720.
27. Hardikar AA, Bhonde RR. Modulating experimental diabetes by treatment with cytosolic extract from the regenerating pancreas. Diabetes Res Clin Pract 1999. 46(3):203-211.
28. Hardikar AA, Karandikar MS, Bhonde RR. Effect of partial pancreatectomy on diabetic status in BALB/c mice. J Endocrinol 1999. 162(2):189-195.
29. Choi KS, Shin JS, Lee JJ, Kim YS, Kim SB, Kim CW. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 2005. 330(4):1299-1305.
30. Xu YX, Chen L, Hou WK, Lin P, Sun L, Sun Y, Dong QY, Liu JB, Fu YL. Mesenchymal stem cells treated with rat pancreatic extract secrete cytokines that improve the glycometabolism of diabetic rats. Transplant Proc 2009. 41(5):1878-1884.
31. Phadnis SM, Joglekar MV, Venkateshan V, Ghaskadbi SM, Hardikar AA, Bhonde RR. Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells. In Vitro Cell Dev Biol Anim 2006. 42(10):283-286.
32. Hakelien AM, Gaustad KG, Collas P. Transient alteration of cell fate using a nuclear and cytoplasmic extract of an insulinoma cell line. Biochem Biophys Res Commun 2004. 316(3):834-841.
33. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004. 117(Pt 14):2971-2981.
34. Huang K, Zhou DH, Huang SL, Liang SH. Agerelated biological characteristics of human bone marrow mesenchymal stem cells from different age donors. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005. 13(6):1049-1053.
35. Drucker DJ, Jin T, Asa SL, Young TA, Brubaker PL. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol 1994. 8(12):1646-1655.
36. Wideman RD, Covey SD, Webb GC, Drucker DJ, Kieffer TJ. A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice. Diabetes 2007. 56(11):2744-2752.
37. Decker K, Goldman DC, Grasch CL, Sussel L. Gata6 is an important regulator of mouse pancreas development. Dev Biol 2006. 298(2):415-429.
38. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005. 106(2):419-427.
39. Hardikar AA, Marcus-Samuels B, Geras-Raaka E, Raaka BM, Gershengorn MC. Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormoneexpressing islet-like cell aggregates. Proc Natl Acad Sci USA 2003. 100(12):7117-7122.
40. Bernard C, Berthault MF, Saulnier C, Ktorza A. Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J 1999. 13(10):1195-1205.
41. Donath MY, Gross DJ, Cerasi E, Kaiser N. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 1999. 48(4):738-744.
42. Kaiser N, Leibowitz G, Nesher R. Glucotoxicity and beta-cell failure in type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2003. 16(1):5-22.
43. Terashima T, Kojima H, Fujimiya M, Matsumura K, Oi J, Hara M, Kashiwagi A, Kimura H, Yasuda H, Chan L. The fusion of bone-marrow-derived proinsulinexpressing cells with nerve cells underlies diabetic neuropathy. Proc Natl Acad Sci USA 2005. 102(35):12525-12530.
44. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 2005. 20(9):1647-1658.
45. Ulrich-Merzenich G, Bhonde RR. Donor site, age and health affect fibroblast growth in culture. In Vitro Cell Dev Biol Anim 1995. 31(7):494-496.
46. Liu XN, Yin Q, Zhang H, Zhu SJ, Wei YJ, Hu SS. Tissue extracts from infarcted myocardium of rats in promoting the differentiation of bone marrow stromal cells into cardiomyocyte-like cells. Biomed Environ Sci 2008. 21(2):110-117.
47. Liu YX, Ji L, Yue W, Yan ZF, Wang J, Xi JF, Zhang R, Nan X, Bai CX, Chen L, Wang YF, Pei XT. Cells extract from fetal liver promotes the hematopoietic differentiation of human embryonic stem cells. Cloning Stem Cells 2009. 11(1):51-60.
48. Li W, He H, Chen YT, Hayashida Y, Tseng SC. Reversal of myofibroblasts by amniotic membrane stromal extract. J Cell Physiol 2008. 215(3):657-664.